Adeno-associated virus vector as a platform for gene therapy delivery

被引：1663

作者：

Wang, Dan ^{[1
,2
,3
]}

Tai, Phillip W. L. ^{[1
,2
,3
]}

Gao, Guangping ^{[1
,2
,3
]}

机构：

[1] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA 01655 USA

[2] Univ Massachusetts, Sch Med, Li Weibo Inst Rare Dis Res, Worcester, MA 01655 USA

[3] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2019年 / 18卷 / 05期

基金：

美国国家卫生研究院;

关键词：

ADENO-ASSOCIATED-VIRUS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; POSTTRANSCRIPTIONAL REGULATORY ELEMENT; RECOMBINANT AAV VECTORS; RATE-LIMITING STEP; IN-VIVO; TRANSGENE EXPRESSION; VIRAL VECTORS; MOUSE MODEL;

D O I：

10.1038/s41573-019-0012-9

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Adeno-associated virus (AAV) vectors are the leading platform for gene delivery for the treatment of a variety of human diseases. Recent advances in developing clinically desirable AAV capsids, optimizing genome designs and harnessing revolutionary biotechnologies have contributed substantially to the growth of the gene therapy field. Preclinical and clinical successes in AAV-mediated gene replacement, gene silencing and gene editing have helped AAV gain popularity as the ideal therapeutic vector, with two AAV-based therapeutics gaining regulatory approval in Europe or the United States. Continued study of AAV biology and increased understanding of the associated therapeutic challenges and limitations will build the foundation for future clinical success.

引用

页码：358 / 378

页数：21

共 315 条

[81] Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons [J].

Duque, Sandra ;

Joussemet, Beatrice ;

Riviere, Christel ;

Marais, Thibaut ;

Dubreil, Laurence ;

Douar, Anne-Marie ;

Fyfe, John ;

Moullier, Philippe ;

Colle, Marie-Anne ;

Barkats, Martine .

MOLECULAR THERAPY, 2009, 17 (07) :1187-1196

[82] Real-Time DNA Sequencing from Single Polymerase Molecules [J].

Eid, John ;

Fehr, Adrian ;

Gray, Jeremy ;

Luong, Khai ;

Lyle, John ;

Otto, Geoff ;

Peluso, Paul ;

Rank, David ;

Baybayan, Primo ;

Bettman, Brad ;

Bibillo, Arkadiusz ;

Bjornson, Keith ;

Chaudhuri, Bidhan ;

Christians, Frederick ;

Cicero, Ronald ;

Clark, Sonya ;

Dalal, Ravindra ;

deWinter, Alex ;

Dixon, John ;

Foquet, Mathieu ;

Gaertner, Alfred ;

Hardenbol, Paul ;

Heiner, Cheryl ;

Hester, Kevin ;

Holden, David ;

Kearns, Gregory ;

Kong, Xiangxu ;

Kuse, Ronald ;

Lacroix, Yves ;

Lin, Steven ;

Lundquist, Paul ;

Ma, Congcong ;

Marks, Patrick ;

Maxham, Mark ;

Murphy, Devon ;

Park, Insil ;

Pham, Thang ;

Phillips, Michael ;

Roy, Joy ;

Sebra, Robert ;

Shen, Gene ;

Sorenson, Jon ;

Tomaney, Austin ;

Travers, Kevin ;

Trulson, Mark ;

Vieceli, John ;

Wegener, Jeffrey ;

Wu, Dawn ;

Yang, Alicia ;

Zaccarin, Denis .

SCIENCE, 2009, 323 (5910) :133-138

[83] VERY MILD MUSCULAR-DYSTROPHY ASSOCIATED WITH THE DELETION OF 46-PERCENT OF DYSTROPHIN [J].

ENGLAND, SB ;

NICHOLSON, LVB ;

JOHNSON, MA ;

FORREST, SM ;

LOVE, DR ;

ZUBRZYCKAGAARN, EE ;

BULMAN, DE ;

HARRIS, JB ;

DAVIES, KE .

NATURE, 1990, 343 (6254) :180-182

[84] A parvovirus isolated from royal python']python (Python']Python regius) is a member of the genus Dependovirus [J].

Farkas, SL ;

Zádori, Z ;

Benko, M ;

Essbauer, S ;

Harrach, B ;

Tijssen, P .

JOURNAL OF GENERAL VIROLOGY, 2004, 85 :555-561

[85] CpG-depleted adeno-associated virus vectors evade immune detection [J].

Faust, Susan M. ;

Bell, Peter ;

Cutler, Benjamin J. ;

Ashley, Scott N. ;

Zhu, Yanqing ;

Rabinowitz, Joseph E. ;

Wilson, James M. .

JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07) :2994-3001

[86] Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors [J].

Ferrari, FK ;

Samulski, T ;

Shenk, T ;

Samulski, RJ .

JOURNAL OF VIROLOGY, 1996, 70 (05) :3227-3234

[87] Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].

Fisher, KJ ;

Gao, GP ;

Weitzman, MD ;

DeMatteo, R ;

Burda, JF ;

Wilson, JM .

JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532

[88] A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease [J].

Flotte, T ;

Carter, B ;

Conrad, C ;

Guggino, W ;

Reynolds, T ;

Rosenstein, B ;

Taylor, G ;

Walden, S ;

Wetzel, R .

HUMAN GENE THERAPY, 1996, 7 (09) :1145-1159

[89] Severe Toxicity in Nonhuman Primates and Piglets with Systemic High-Dose Administration of Adeno-Associated Virus Serotype 9-Like Vectors: Putting Patients First [J].

Flotte, Terence R. ;

Buening, Hildegard .

HUMAN GENE THERAPY, 2018, 29 (03) :283-284

[90] Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α1-Antitrypsin: Interim Results [J].

Flotte, Terence R. ;

Trapnell, Bruce C. ;

Humphries, Margaret ;

Carey, Brenna ;

Calcedo, Roberto ;

Rouhani, Farshid ;

Campbell-Thompson, Martha ;

Yachnis, Anthony T. ;

Sandhaus, Robert A. ;

McElvaney, Noel G. ;

Mueller, Christian ;

Messina, Louis M. ;

Wilson, James M. ;

Brantly, Mark ;

Knop, David R. ;

Ye, Guo-jie ;

Chulay, Jeffrey D. .

HUMAN GENE THERAPY, 2011, 22 (10) :1239-1247

← 4 5 6 7 8 9 10 11 12 13 →